Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01654263
Show Display Options
Rank Status Study
1 Completed A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine
Condition: Pneumococcal Infection
Intervention: Biological: Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]

Study has passed its completion date and status has not been verified in more than two years.